Antitussive/antihist aminic/decongestant compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 9, 2002
Grant Date -
N/A
app pub date -
Jan 26, 2001
filing date -
Jan 26, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Tannate compositions are disclosed consisting essentially of carbetapentane tannate, pyrilamine tannate and phenylephrine tannate are effective when administered orally for the symptomatic relief of cough associated with respiratory tract conditions such as the common cold, bronchial asthma, acute and chronic bronchitis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully